(FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -742.86%-720K | -68.82%-585.95K | -224.85%-79.16K | -116.85%-62.48K | -69.42%7.59K | 154.88%112K | -528.77%-347.08K | -69.54%63.4K | 222.85%370.84K | 112.98%24.83K |
Net income from continuing operations | 557.83%546K | 9,677.87%924.36K | 47.01%-218.46K | 171.19%244.72K | -197.46%-404.17K | -92.63%83K | -100.94%-9.65K | -202.20%-412.27K | 165.96%90.24K | 354.47%414.69K |
Operating gains losses | ---- | ---- | ---- | ---- | --747 | ---- | ---- | ---- | --3.02K | ---- |
Depreciation and amortization | 10.47%380K | 12.80%96.88K | 16.33%99.36K | 12.67%97.05K | 0.17%86.71K | -6.03%344K | -2.38%85.89K | -2.75%85.41K | -0.97%86.14K | -16.18%86.56K |
Asset impairment expenditure | -61.76%26K | ---- | ---- | ---- | ---- | 223.16%68K | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | -16.32%323K | -58.26%-302.44K | -18.48%389.13K | -218.58%-175.8K | 949.71%412.11K | 152.71%386K | 73.90%-191.1K | --477.34K | --148.26K | ---48.5K |
Remuneration paid in stock | -18.75%78K | -12.56%23.09K | -11.88%23.53K | -26.56%19.61K | -27.29%11.77K | 178.26%96K | --26.41K | --26.7K | -22.60%26.7K | --16.18K |
Deferred tax | ---724K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non cashItems | -10.66%-716K | -16.40%-223.39K | 4.96%-168.57K | -2.09%-157.55K | -35.29%-166.94K | -3.78%-647K | -117.69%-191.92K | 30.71%-177.37K | -11.71%-154.32K | 12.58%-123.39K |
Change In working capital | -190.37%-633K | -208.09%-405.72K | -421.05%-204.15K | -152.99%-90.51K | 121.01%67.37K | 44.93%-218K | 42.72%-131.69K | 334.95%63.59K | 215.11%170.81K | -3,480.81%-320.7K |
-Change in receivables | -300.98%-409K | 42.88%-65K | 11.46%-113.38K | -354.73%-365.99K | 3,635.57%135.38K | 1.39%-102K | -20.84%-113.79K | -66.84%-128.06K | 165.81%143.68K | -101.34%-3.83K |
-Change in inventory | -62.76%-319K | -485.15%-294.14K | -760.10%-189.54K | 253.96%142.96K | 110.43%21.73K | 50.29%-196K | 143.06%76.37K | 176.95%28.71K | -6,855.13%-92.85K | -16.80%-208.23K |
-Change in prepaid assets | 103.08%2K | -11.31%-124.24K | 986.80%72.71K | -95.47%1.02K | 62.77%52.51K | 30.52%-65K | -17.96%-111.62K | -109.90%-8.2K | 171.01%22.56K | 164.60%32.26K |
-Change in payables and accrued expense | -67.11%49K | 57.65%33.66K | -84.77%26.07K | 34.99%131.51K | -0.95%-142.24K | -24.86%149K | -84.65%21.35K | 3,956.17%171.13K | -5.45%97.42K | -192.94%-140.9K |
-Change in other working capital | 1,200.00%44K | ---- | ---- | ---- | ---- | -38.55%-4K | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -742.86%-720K | -68.83%-585.96K | -224.85%-79.16K | -116.85%-62.48K | -69.43%7.59K | 154.88%112K | -528.77%-347.08K | -69.54%63.4K | 222.85%370.84K | 112.98%24.83K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,171.02%-5.66M | -1,913.90%-3.24M | 104.29%70.47K | 29.87%-1.14M | -137.20%-1.35M | 412.73%528K | 126.20%178.6K | -1,911.10%-1.64M | -868.86%-1.63M | 1,616.12%3.62M |
Net PPE purchase and sale | -50.00%-27K | 102.42%142 | ---10.81K | -279.05%-8.34K | 19.51%-8K | -510.17%-18K | -193.30%-5.87K | --0 | -131.58%-2.2K | ---9.93K |
Net intangibles purchas and sale | ---384K | ---140.84K | ---101.28K | ---84.25K | ---57.63K | --0 | --0 | --0 | --0 | --0 |
Net investment purchase and sale | -5,800.99%-5.96M | -1,112,108.47%-3.28M | --0 | 31.53%-1.22M | -141.72%-1.46M | 87.45%-101K | 100.04%295 | -680.18%-1.82M | -1,796.07%-1.78M | 3,400.00%3.5M |
Interest received (cash flow from investment activities) | 10.66%716K | -1.43%181.53K | 1.68%182.55K | 9.30%171.5K | 42.74%180.42K | 2.10%647K | 101.11%184.17K | -44.58%179.53K | 46.02%156.91K | 14.14%126.39K |
Net other investing changes | ---- | ---- | ---1 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,171.02%-5.66M | -1,913.90%-3.24M | 104.29%70.46K | 29.87%-1.14M | -137.20%-1.35M | 412.73%528K | 126.20%178.6K | -1,911.10%-1.64M | -868.86%-1.63M | 1,616.12%3.62M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 24.26%-103K | 147.01%12.36K | -8.50%-39.68K | -8.51%-39.68K | 1.56%-36K | 7.03%-136K | 28.11%-26.29K | 0.00%-36.57K | 0.00%-36.57K | 0.00%-36.57K |
Net issuance payments of debt | 24.26%-103K | 147.01%12.36K | -8.50%-39.68K | -8.51%-39.68K | 1.56%-36K | 7.03%-136K | 28.11%-26.29K | 0.00%-36.57K | 0.00%-36.57K | 0.00%-36.57K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 24.26%-103K | 147.01%12.36K | -8.50%-39.68K | -8.51%-39.68K | 1.56%-36K | 7.03%-136K | 28.11%-26.29K | 0.00%-36.57K | 0.00%-36.57K | 0.00%-36.57K |
Net cash flow | ||||||||||
Beginning cash position | 5.44%9.77M | -28.69%7.11M | -38.21%7.15M | -34.76%8.4M | 5.44%9.77M | -5.31%9.27M | 0.62%9.97M | 20.10%11.58M | 31.76%12.87M | -5.31%9.27M |
Current changes in cash | -1,385.52%-6.48M | -1,858.30%-3.81M | 97.00%-48.37K | 3.82%-1.24M | -138.11%-1.37M | 197.07%504K | 69.44%-194.77K | -715.55%-1.61M | -917.78%-1.29M | 21,079.64%3.6M |
End cash Position | -66.31%3.29M | -66.31%3.29M | -28.69%7.11M | -38.21%7.15M | -34.76%8.4M | 5.44%9.77M | 5.44%9.77M | 0.62%9.97M | 20.10%11.58M | 31.76%12.87M |
Free cash from | -1,303.19%-1.13M | -105.88%-726.65K | -401.63%-191.25K | -142.07%-155.07K | -489.50%-58.03K | 145.40%94K | -547.06%-352.94K | -69.54%63.4K | 221.74%368.64K | 107.79%14.9K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data